No Data
Xiamen Kingdomway Group (002626.SZ): Chengxin Pharmaceutical has been re-certified as a high-tech enterprise.
Gelonghui reported on February 14 that Xiamen Kingdomway Group (002626.SZ) announced that its controlling subsidiary Jiangsu Chengxin Pharmaceutical Co., Ltd. (referred to as "Chengxin Pharmaceutical") has recently received the latest "High-tech Enterprise Certificate" issued jointly by the Jiangsu Provincial Department of Science and Technology, the Jiangsu Provincial Department of Finance, and the State Taxation Administration of Jiangsu Province. The certificate number is: GR202432005491, issued on November 19, 2024, and valid for three years.
Vit-Best Nutrition Appoints New President
Xiamen Kingdomway Group (SZSE:002626) Seems To Use Debt Rather Sparingly
Xiamen Kingdomway Group (002626.SZ): Xiamen Kingdomway Group has opened a store on Xiaohongshu.
Gelonghui, January 14th丨Xiamen Kingdomway Group (002626.SZ) stated on the investor interaction platform that its wholly-owned subsidiary, Xiamen Kingdomway Holding Company, has opened a store on Xiaohongshu.
Xiamen Kingdomway Group (002626.SZ): has obtained a USA invention patent certificate.
On December 16, Gelonghui reported that Xiamen Kingdomway Group (002626.SZ) announced that the company and its wholly-owned subsidiary Inner Mongolia Kingdomway Pharmaceutical Co., Ltd., as well as its wholly-owned subsidiary Xiamen Kingdomway Biotechnology (Jiangsu) Co., Ltd., recently received an invention patent certificate issued by the USA Patent and Trademark Office. The invention is titled: ANTI-AGING DRUG COMBINATION AND USE THEREOF, patent number: US12,156,882B2. The effective period (protection period) is twenty years (calculated from the date of application). This invention.
Xiamen Kingdomway Group (SZSE:002626) Sheds CN¥378m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years